Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Self-monitoring of blood glucose as control tool in the different management contexts for Type 2 Diabetes Mellitus. What is its current role in non-insulin users? ; Automonitoreo glicémico como herramienta de control en los distintos contextos de manejo para diabetes mellitus tipo 2 ¿Cuál es su rol actual en no-usuarios de insulina?

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • بيانات النشر:
      Universidad Nacional de Colombia - Sede Bogotá - Facultad de Medicina
    • الموضوع:
      2019
    • Collection:
      Universidad Nacional de Colombia: Portal de Revistas UN
    • نبذة مختصرة :
      Introduction: Self-monitoring blood glucose (SMBG) has been considered a key element in the management of Type 2 Diabetes Mellitus (T2DM). However, its role in glycemic control in non-insulin users has been long discussed.Objective: To conduct a narrative literature review of the benefits of SMBG in non-insulin-treated patients with T2DM.Materials and Methods: A scientific literature search was conducted in the following databases: Pubmed, ScienceDirect, Embase, SciELO, Cochrane and Medline. Relevant articles were selected according to the established criteria. In addition, some studies included in the references of the initially selected articles were added to the review since they were considered relevant for its objective.Results: The following records were included in the review: 14 controlled clinical trials, 13 observational studies, 10 clinical practice guidelines, 7 narrative reviews, 5 meta-analyses, and 1 systematic review.Conclusion: based on the evidence found in this review it is possible to say that the use of SMBG in patients with T2DM is beneficial and that it has a positive impact on non-insulin users in terms of achieving glycemic control and defining therapeutic changes. ; Introducción. El automonitoreo glicémico es considerado un elemento clave en el manejo de la diabetes mellitus tipo 2; sin embargo, su rol en el control glicémico en pacientes no-usuarios de insulina ha sido discutido a lo largo de los años.Objetivo. Realizar una revisión narrativa de la literatura acerca de los beneficios del automonitoreo glicémico en pacientes con diabetes mellitus tipo 2 no-usuarios de insulina.Materiales y métodos. Se realizó una búsqueda de literatura científica en las bases de datos PubMed, ScienceDirect, Embase, SciELO, Cochrane y Medline. Se seleccionaron artículos pertinentes según criterio y se agregaron algunos de los mencionados en las referencias de las publicaciones seleccionadas de la búsqueda inicial que tenían utilidad para la revisión.Resultados. Se incluyeron 14 ensayos clínicos ...
    • File Description:
      application/pdf; text/html; application/xml
    • Relation:
      https://revistas.unal.edu.co/index.php/revfacmed/article/view/69687/72441; https://revistas.unal.edu.co/index.php/revfacmed/article/view/69687/72794; https://revistas.unal.edu.co/index.php/revfacmed/article/view/69687/76296; Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94(3):311-21. http://doi.org/cn622s.; Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32(2):287-94. http://doi.org/bskzr3.; American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596-615. http://doi.org/ftcjfb.; Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, et al. The evolving diabetes burden in the United States. Ann Intern Med. 2004;140(11):945-50. http://doi.org/f3vm6p.; Cowie CC, Rust KF, Byrd-Holt DD, Eberhardt MS, Flegal KM, Engelgau MM, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care. 2006;29(6):1263-8. http://doi.org/c4b286.; UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-65. http://doi.org/ctn95c.; Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103-17. http://doi.org/dnj73s.; Nauck MA, Haastert B, Trautner C, Müller UA, Nauck MA, Heinemann L, et al. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment. Diabetologia. 2014;57(5):868-77. http://doi.org/f5x8gm.; Clar C, Barnard K, Cummins E, Royle P, Waugh N. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010;14(12):1-140. http://doi.org/cpqp.; Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, et al. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol Assess. 2009;13(15):1-50. http://doi.org/c3cn.; Gruesser M, Hartmann P, Schlottmann N, Joergens V. Structured treatment and teaching programme for type 2 diabetic patients on conventional insulin treatment: evaluation of reimbursement policy. Patient Educ Couns. 1996;29(1):123-30. http://doi.org/fd7sqz.; Cheng AY, Lau DC. The Canadian Diabetes Association 2014 clinical practice guidelines-raising the bar and setting higher standards! Can J Diabetes. 2013;37(3):137-8. http://doi.org/c3cp.; American Diabetes Association. Standards of medical care in diabetes-2014. Diabetes Care. 2014;37(Suppl 1):S14-80. http://doi.org/twn.; Schnell O, Hanefeld M, Monnier L. Self-monitoring of blood glucose: a prerequisite for diabetes management in outcome trials. J Diabetes Sci Technol. 2014;8(3):609-14. http://doi.org/f65qs9.; Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86. http://doi.org/fxfkdk.; Malanda UL, Welschan LM, Riphagen II, Dekker JM, Nijpels G, Bot SD. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012;1(2):CD005060. http://doi.org/fz4cqx.; Organización Panamericana de la Salud (OPS). Guías ALAD de diagnóstico, control y tratamiento de la Diabetes Mellitus Tipo 2. Washington D.C.: OPS; 2013.; Standards of medical care in diabetes-2017: Summary of Revisions. Diabetes Care. 2017;40(Suppl 1):S4-S5. http://doi.org/c3cr.; Elgart JF, González L, Prestes M, Rucci E, Gagliardino JJ. Frequency of self-monitoring blood glucose and attainment of HbA1c target values. Acta Diabetol. 2016;53(1):57-62. http://doi.org/f789gk.; Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262-7. http://doi.org/bvz24x.; Kirk JK, Stegner J. Self-monitoring of blood glucose: practical aspects. J Diabetes Sci Technol. 2010;4(2):435-9. http://doi.org/f3v9wj.; Hirsch IB, Bode BW, Childs BP, Close KL, Fisher WA, Gavin JR, et al. Self-monitoring of blood glucose (SMBG) in insulin- and non-insulin-using adults with diabetes: consensus recommendations for improving SMBG accuracy, utilization, and research. Diabetes Technol Ther. 2008;10(6):419-39. http://doi.org/cnbndw.; Bunker K. 2010 Consumer Guide. Blood glucose meters. Diabetes Forecast. 2010;63(1):32-41.; Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, et al. National standards for diabetes self-management education. Diabetes Care. 2010;33(Suppl. 1):S89-96. http://doi.org/bn8hpw.; Al-Keilani MS, Almomani BA, Al-Sawalha NA, Shhabat BA. Self-Monitoring of Blood Glucose among Patients with Diabetes in Jordan: Perception, Adherence, and Influential Factors. Diabetes Res Clin Pract. 2017;126:79-85. http://doi.org/gbh89q.; Chidum E, Agbai D, Fidelis O, Teppany S, Martina R, Rian E, et al. Self-monitoring of blood glucose improved glycemic control and 10-year coronary heart disease risk profile of type 2 diabetic patients. Chin Med J. 2011;124(2):166-71.; Parkin CG, Hinnen DA, Tetrick DL. Effective use of structured self-management of blood glucose in type 2 diabetes: lessons from the STeP study. Clin Diabetes. 2011;29(4):131-8. http://doi.org/bt5fr6.; Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, et al. Consensus statement on self-monitoring of blood glucose in diabetes: a European perspective. Diabetes, Stoffwechsel und Herz. 2009;18(4):285-9.; Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, Williamson D, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14(5):737-52. http://doi.org/dkrzxh.; World Health Organization (WHO). Adherence to long term therapies evidence for action. Geneva: WHO; 2003.; García de la Torre N, Durán A, Del Valle L, Fuentes M, Barca I, Martín P, et al. Early Management of type 2 diabetes based on a SMBG strategy: the way to diabetes regression - the St Carlos Study: a 3-year, prospective, randomized, clinic-based, interventional study with parallel groups. Acta Diabetol. 2013;50(4):607-14. http://doi.org/f4853b.; Durán A, Martín P, Runkle I, Pérez N, Abad R, Fernández M, et al. Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: The St Carlos Study, a prospective randomized clinic based interventional study with parallel groups. J Diabetes. 2010;2(3):203-11. http://doi.org/dgmfb8.; American Diabetes Association. 5. Glycemic targets. Diabetes Care. 2016;39(Suppl 1):S39-S46. http://doi.org/c3ct.; Wambui-Charity K, Kumar AMV, Hinderaker SG, Chinnakali P, Pastakia SD, Kamano J. Do diabetes mellitus patients adhere to self-monitoring of blood glucose (SMBG) and is this associated with glycemic control? Experiences from a SMBG program in western Kenya. Diabetes Res Clin Pract. 2016;112:37-43. http://doi.org/f789gp.; Poolsup N, Suksomboon N, Rattanasookchit S. Meta-analysis of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients: an update. Diabetes Technol Ther. 2009;11(12):775-84. http://doi.org/cw3wss.; Towfigh A, Romanova M, Weinreb JE, Munjas B, Suttorp MJ, Zhou A, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care. 2008;14(7): 468-75.; Claude-Mbanya J, Aschner P, Chan JCN, Jose-Gagliardino J, Saji J. Self-monitorigin of blood glucose (SMBG) and glycemic control in Cameroon: Results of the International Diabetes Management Practices Study (IDMPS). Diabetes Res Clin Pract. 2017;126:198-201. http://doi.org/gbh8z9.; International Diabetes Federation. Clinical Practice Guidelines: self-monitoring of blood glucose in non-insulin treated type 2 diabetes. Brussels: International Diabetes Federation; 2009.; Young LA, Buse JB, Weaver MA, Vu MB, Mitchell CM, Blakeney T, et al. Glucose Self-monitoring in Non-Insulin-Treated patients with Type 2 Diabetes in primary care settings: A randomized trial. JAMA Intern Med. 2017;177(7):920-9. http://doi.org/css3.; Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, et al. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with noninsulin treated type 2 diabetes. BMJ. 2012;344:e486. http://doi.org/c3cv.; Weinger K, Beverly EA, Lee Y, Sitnokov L, Ganda OP, Caballero AE. The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial. Arch Intern Med. 2011;171(22):1990-9. http://doi.org/d3sv48.; Klonoff DC, Blonde L, Cembrowski G, Chacra AR, Charpentier G, Colagiuri S, et al. Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol. 2011;5(6):1529-48. http://doi.org/f3wj69.; Allemann S, Houriet C, Diem P, Stettler C. Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin. 2009;25(12):2903-13. http://doi.org/c573v8.; Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, et al. Addressing schemes of self-monitoring of blood glucose in type 2 diabetes: A European perspective and expert recommendations. Diabetes Technol Ther. 2011;13(9):959-65. http://doi.org/bv8d84.; Evans JM, Mackison D, Emslie-Smith A, Lawton J. Self-monitoring of blood glucose in type 2 diabetes: cross-sectional analyses in 1993, 1999 and 2009. Diabet Med. 2012;29(6):792-5. http://doi.org/c3cw.; Karter AJ, Ackerson LM, Darbinian JA, D’Agostino RB Jr, Ferrara A, Liu J, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes Registry. Am J Med. 2001;111(1):1-9. http://doi.org/b7x49q.; Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care. 2003;26(6):1759-63. http://doi.org/dnskw8.; Rutten G, van Eijk J, de Nobel E, Beek M, van der Velden H. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Fam Pract. 1990;7(4):273-8. http://doi.org/d38cq7.; Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol. 1994;31(4):215-9. http://doi.org/dm9ffz.; Mohan V, Ravikumar R, Poongothai S, Amutha A, Sowmya S, Karkhuzali K, et al. A single-center, open, comparative study of the effect of using self-monitoring of blood glucose to guide therapy on preclinical atherosclerotic markers in type 2 diabetic subjects. J Diabetes Sci Technol. 2010;4(4):942-8. http://doi.org/f3wb4b.; https://revistas.unal.edu.co/index.php/revfacmed/article/view/69687
    • Rights:
      Derechos de autor 2019 Revista de la Facultad de Medicina ; http://creativecommons.org/licenses/by/3.0/
    • الرقم المعرف:
      edsbas.E33413F6